Persistent URL of this record https://hdl.handle.net/1887/100422
In Collections
This item can be found in the following collections:
Secukinumab, a Monoclonal Antibody to Interleukin-17A, Provides Significant and Sustained Inhibition of Joint Structural Damage in Active Psoriatic Arthritis Regardless of Prior TNF Inhibitors or Concomitant Methotrexate: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- All authors
- Heijde, D. van der; Landewe, R.B.M.; Mease, P.; McInnes, I.B.; Conaghan, P.G.; Pricop, L.; Ligozio, G.; Richards, H.; Mpofu, S.
- Date
- 2014-10-31
- Journal
- Arthritis and Rheumatology
- Volume
- 66
- Pages
- S424 - S425